Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 5971 AL 5985

New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc

Corona C, Pensalfini A, Frazzini V, Sensi SL.

Cell Death Dis. 2011 Jun 23;2(6):e176. doi: 10.1038/cddis.2011.57.

In silico design and search for acetylcholinesterase inhibitors in Alzheimer's disease with a suitable pharmacokinetic profile and low toxicity

da Silva VB, de Andrade P, Kawano DF, Morais PA, de Almeida JR, Carvalho I, Taft CA, da Silva CH.

Future Med Chem. 2011 Jun;3(8):947-60. doi: 10.4155/fmc.11.67.

Effects of galantamine in Alzheimer's disease: double-blind withdrawal studies evaluating sustained versus interrupted treatment

Gaudig M, Richarz U, Han J, Van Baelen B, Schäuble B.

Curr Alzheimer Res. 2011 Nov;8(7):771-80. doi: 10.2174/156720511797633205.

Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type

Dhillon S.

Drugs. 2011 Jun 18;71(9):1209-31. doi: 10.2165/11206380-000000000-00000.

The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease

Ling S, Zhou J, Rudd JA, Hu Z, Fang M.

Anat Rec (Hoboken). 2011 Aug;294(8):1307-18. doi: 10.1002/ar.21425. Epub 2011 Jun 29.

Nuclear receptors as therapeutic targets for Alzheimer's disease

Mandrekar-Colucci S, Landreth GE.

Expert Opin Ther Targets. 2011 Sep;15(9):1085-97. doi: 10.1517/14728222.2011.594043. Epub 2011 Jul 1.

Combination therapy for Alzheimer's disease

Patel L, Grossberg GT.

Drugs Aging. 2011 Jul 1;28(7):539-46. doi: 10.2165/11591860-000000000-00000.

Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease

Wallace TL, Porter RH.

Biochem Pharmacol. 2011 Oct 15;82(8):891-903. doi: 10.1016/j.bcp.2011.06.034. Epub 2011 Jul 2.

The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer's disease in rats

Tramontina AC, Wartchow KM, Rodrigues L, Biasibetti R, Quincozes-Santos A, Bobermin L, Tramontina F, Gonçalves CA.

J Neural Transm (Vienna). 2011 Nov;118(11):1641-9. doi: 10.1007/s00702-011-0680-z. Epub 2011 Jul 10.

Do tocotrienols have potential as neuroprotective dietary factors?

Frank J, Chin XW, Schrader C, Eckert GP, Rimbach G.

Ageing Res Rev. 2012 Jan;11(1):163-80. doi: 10.1016/j.arr.2011.06.006. Epub 2011 Jul 7.

Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies

Ha GT, Wong RK, Zhang Y.

Chem Biodivers. 2011 Jul;8(7):1189-204. doi: 10.1002/cbdv.201000269.

Family caregivers at risk: who are they?

Gonzalez EW, Polansky M, Lippa CF, Walker D, Feng D.

Issues Ment Health Nurs. 2011;32(8):528-36. doi: 10.3109/01612840.2011.573123.

Recovery of hippocampal network connectivity correlates with cognitive improvement in mild Alzheimer's disease patients treated with donepezil assessed by resting-state fMRI

Goveas JS, Xie C, Ward BD, Wu Z, Li W, Franczak M, Jones JL, Antuono PG, Li SJ.

J Magn Reson Imaging. 2011 Oct;34(4):764-73. doi: 10.1002/jmri.22662. Epub 2011 Jul 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias